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Abstract 
 
Actin-based protrusions are reinforced through positive feedback, but it is 
unclear what restricts their size, or limits positive signals when they retract or 
split.  We identify an evolutionarily conserved regulator of actin-based 
protrusion: CYRI (CYFIP-related Rac interactor).  CYRI binds activated Rac1 via 
a Domain of Unknown Function DUF1394, shared with CYFIP, defining DUF1394 
as a Rac1-binding module.  CYRI-depleted cells have broad lamellipodia enriched 
in Scar/WAVE, but reduced protrusion-retraction dynamics.  Pseudopods 
induced by optogenetic Rac1 activation in CYRI-depleted cells are larger and 
longer-lived. Conversely, CYRI overexpression suppresses recruitment of active 
Scar/WAVE to the cell edge, resulting in short-lived, unproductive 
protrusions.  CYRI thus focusses protrusion signals and regulates pseudopod 
complexity by inhibiting Scar/WAVE-induced actin polymerization.  It thus 
behaves like a “local inhibitor” predicted in widely accepted mathematical 
models, but not previously identified in cells.  CYRI therefore regulates 
chemotaxis, cell migration and epithelial polarisation by controlling polarity and 
plasticity of protrusions.   
 3 
Introduction 
 
Cell migration is an ancient and fundamental mechanism whereby cells exert 
control over interactions with their environment.  The actin cytoskeleton is the 
main driver of cell migration, with dozens of proteins controlling actin 
organisation1. Actin protrusions, or pseudopods, govern migration, however the 
feedback loops controlling assembly, splitting and disassembly of these 
structures is an area of active debate2.   
 
The Scar/WAVE complex is the main driver of Arp2/3-mediated branched actin 
networks underlying pseudopod generation. The complex consists of five 
subunits CYFIP, NCKAP1, Scar/WAVE, ABI, HSPC300 (nomenclature in 
Supplementary Table 1).  The main Arp2/3 activating subunit, Scar/WAVE, is 
autoinhibited until signals trigger a conformational change, exposing an Arp2/3 
activation sequence 3, 4.  The Scar/WAVE complex is recruited to acidic 
phospholipids in the plasma membrane via a patch of basic charges3 and via 
interaction with the small GTPase Rac15-7. 
 
Many motile cell types steer by splitting pseudopods into two or more 
daughters; selecting pseudopods from the split for retraction/maintenance 
provides a directional bias steering cells up chemotactic gradients8.  Actin and 
associated signal transduction networks form excitable systems that propagate 
in waves and self-limit to drive protrusion and retraction1, 9, 10.  Actin and 
associated cytoskeletal components likely control their own excitability in 
concert with signaling lipids, but dynamic interplay between “on” and “off” 
signals is essential for migration to be plastic and responsive. 
 
Negative regulators of Arp2/3 complex include Gadkin, which sequesters Arp2/3 
at the trans Golgi network and endosomes11.  Another inhibitor, Arpin mimics 
the activating sequence of Scar/WAVE but inhibits the Arp2/3 complex 12.  Here, 
we describe a negative regulator of the Scar/WAVE complex, CYRI (encoded by 
the FAM49 gene), an evolutionarily conserved protein that mimics the Rac1 
interaction domain of CYFIP and promotes dynamic pseudopod splitting. 
 
 
Results 
CYRI is an evolutionarily conserved N-myristoylated protein with 
homology to CYFIP 
We sought new Scar/WAVE complex interactors by precipitating GFP-fused 
NAP1 (for nomenclature see Supplementary Table 1) from napA knockout 
rescued Dictyostelium cells.  Reversible formaldehyde crosslinking in cellulo13 
stabilised transient interactions and GFP-Trap immunocapture recovered 
Scar/WAVE, ABI, HSPC300 and PIR121.  Another interactor was identified as 
Fam49 (FAMily of unknown function 49; Fig 1a and Supplementary Table 2). 
Although FAM49 did not co-precipitate with the Scar/WAVE complex in the 
absence of crosslinking, we focused on it for two reasons.  Firstly, FAM49 is 
highly conserved across evolution and is roughly co-conserved with the 
Scar/WAVE complex14,15 (Supplementary Fig.1a). Secondly, Pfam and InterPro 
identified FAM49 as uniquely sharing a DUF1394 domain with the Scar/WAVE 
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complex subunit CYFIP (Fig. 1b and Supplementary Fig.1b).  FAM49 proteins 
comprise mostly DUF1394, while CYFIP proteins contain a cytoplasmic fragile X 
interaction domain16 (Fig. 1b).   We renamed FAM49 to CYRI for CYFIP-related 
Rac1 Interactor, in mammals, represented by CYRI-A (FAM49-A) and CYRI-B 
(FAM49-B) and henceforth we use this nomenclature. 
 
The DUF1394 region of CYFIP, highlighted in red (PDB 3P8C and Fig. 1c) partly 
overlaps with the published Scar/WAVE complex Rac1 interaction site, in 
particular R190 in CYFIP13 (Fig. 1c, Black arrow and blue balls).  Modeling the 
structure of the DUF1394 of CYRI-B using Phyre2, reveals structural similarities 
with CYFIP (PDB 3P8C and Fig. 1d).  The analogous R161 of CYRI (Fig 1d blue 
sidechains, and e red box) is part of a highly conserved 33-amino acid stretch 
(>75% similarity) across diverse phyla (Supplementary Fig. 1b-c). R160 is also 
conserved in CYRI but replaced by lysine in CYFIP (Fig. 1d-e and 
Supplementary Fig. 1b-c). 
 
The N-terminal glycine-2 of CYRI proteins encodes a putative myristoylation 
site17-19 (Fig. 1f), which is not conserved in CYFIP.  We confirmed the 
myristoylation of CYRI-B by assessing the incorporation of myristate analogue 
(C14:0-azide) onto G2 using CLICK chemistry in cellulo. Mutation of this glycine 
to alanine abolishes the CLICK signal (Fig. 1 g-h). 
 
In summary, we have defined CYRI, an evolutionarily conserved protein with a 
putative Rac1-binding DUF1394 module.  Furthermore, N-terminal 
myristoylation suggests CYRI may dynamically associate with the plasma 
membrane20, where active Rac1 stimulates the Scar/WAVE complex to catalyse 
lamellipodial expansion. 
 
CYRI interacts directly with activated Rac1 in vitro 
Homology between CYRI and CYFIP (Supplementary Fig. 1b), suggested 
potential interaction with Rac1. Yeast two-hybrid screening with Rac1G12V as bait 
retrieved CYRI-B from multiple cDNA libraries (Supplementary Fig. 2a). The 
core interacting sequence of CYRI-B encompasses amino acids 30-236 (hereafter 
the Rac Binding Domain - RBD), (Supplementary Fig. 2b-c). GFP-RBD expressed 
in CHL-1 human melanoma cells interacted selectively with GST-Rac1Q61L but not 
GST-Rac1WT.  Mutation of CYRI-B R160 or R161 (in GFP-RBD) to aspartic acid 
abrogated this interaction (Fig. 2a-c and Supplementary Fig. 7). GST-CYRI-B 
RBD and MBP-Rac1 also showed robust interaction (Supplementary Fig. 2d-f 
and Supplementary Fig. 7).  In this assay, CYRI does not co-precipitate with 
Rac1T17N, Rac1G12V, or Rac1 WT, likely due to the low affinity of CYRI-B for Rac1. 
However, the double mutant Rac1 P29S/Q61L, recently shown to have a high affinity 
for the Scar/WAVE complex21, displayed enhanced binding to CYRI-B RBD (~3-
3.5-fold increase) over Rac1Q61L  but no enhanced binding to Pak1-CRIB 
(Supplementary Fig. 2 d-f and Supplementary Fig. 7).  Using surface plasmon 
resonance, immobilised CYRI-B RBD specifically interacted with Rac1 Q61L with a 
Kd of 27 µM and the reverse assay, with Rac1 Q61L immobilised returned a Kd of 
22 µM (Fig. 2g).  As CYRI-RBD shows no homology to CRIB (Cdc42 and Rac 
interaction binding) motifs, we probed the specificity of the interaction of CYRI 
between Rac1, RhoA and Cdc42. Once again, CYRI-RBD interacted robustly with 
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Rac1Q61L but not with constitutively active RhoAQ63L or Cdc42Q61L (Fig. 2d, 
Supplementary Fig. 2g-h and Supplementary Fig. 7).  Thus CYRI-B RBD 
interacts specifically with active Rac1. Two conserved basic residues in the 
DUF1394 (conserved in CYFIP) mediate this interaction.  This suggests a signal-
regulated interaction between active Rac1 and CYRI, similar to the Rac1-CYFIP 
interaction, defining DUF1394 as an active Rac1 interaction module. 
 
CYRI interacts with active Rac1 in cells  
We next explored the Rac1-CYRI interaction in cells.  Proximity ligation22 
revealed an interaction between Rac1WT and CYRI-B in COS-7 cells, as well as a 
stronger interaction between Rac1Q61L (Fig. 2h-i and Supplementary Figure 2i-
l).  Mutation of key arginines in CYRI-BR160/161-HA abolished this interaction and 
dominant negative Rac1T17N showed no interaction (Fig. 2 h-I and 
Supplementary Fig. 2i-l).   Targetting either CYRI or Rac1A to mitochondria23  
(Figure 2j) in Dictyostelium, revealed that CYRIWT, but not CYRI mutated for the 
analogous R155/156D, strongly co-recruits active Rac1A P29S/ Q61L. The Pearson’s 
coefficient of fluorescence correlation (PCC) for Rac1A-mCherry-mito and the 
GFP-fusions revealed a PCC 0.77 for CYRIWT; and 0.05 for CYRIR155/156D, where 1 = 
perfect, 0= no correlation and -1 = excluded. The PCC for Rac1A-mCherry and 
GFP-mito-fusions were: CYRI WT 0.44 and CYRI R155/156D -0.23. CYRI-GFP did not 
co-localise with a mitochondrial reporter (PCC = -0.06).  Thus, CYRI interacts 
with activated Rac1, mediated by key conserved arginines, in both mammalian 
and Dictyostelium cells. 
 
CYRI opposes recruitment of the Scar/WAVE complex to lamellipodia 
Knockdown or knockout of CYRI-B by siRNA or CRISPR in COS-7 or CHL-1 cells 
did not affect proliferation, but promoted unusually large and broad lamellipodia 
highly enriched in WAVE2 (Fig. 3a-b, Supplementary Fig. 3a-g and 
Supplementary Fig. 7).  Cells spread over a larger area and adopted a “fried-
egg” phenotype, correlating with an increase in circularity (Fig. 3c-d, 
Supplementary Fig. 3e-g). Expression levels of Scar/WAVE complex subunits 
are not obviously altered in cyri-b knockout cells (Supplementary Fig. 3h and 
Supplementary Fig. 7).  Cell area and circularity were both rescued by re-
expression of untagged CYRI-BWT, but not the Rac1-nonbinding R160/161D 
mutant (Fig. 3e-f, Supplementary Figure 3i-k and Supplementary Fig. 7).  
CYRI-BG2A which cannot be N-myristoylated failed to rescue the phenotype (Fig. 
3g-h, Supplementary 3l-m and Supplementary Fig. 7), reinforcing the 
importance of CYRI lipid modification. cyri knockout Dictyostelium cells also 
showed enhanced recruitment of the Scar/WAVE complex (GFP-HSPC300 
reporter) to a much broader leading edge (Supplementary Fig. 3n – yellow 
dotted line and Supplementary Movie 1). Moreover, Scar/WAVE patches in 
cyri knockout cells are ill-defined but longer-lived, suggesting CYRI’s ability to 
suppress Scar/WAVE complex activity outside of active protrusions. 
(Supplementary Fig. 3n, heat map).  We conclude that CYRI, via its interaction 
with active Rac1 and membrane targetting, opposes active Scar/WAVE complex 
at the plasma membrane and thus drives the formation of more focussed and 
sharper lamellipodial protrusions. 
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To determine the requirement for Rac1 for the phenotype of cyri-b knockout 
cells, we co-depleted Rac1 and CYRI-B from mouse tail skin fibroblasts with 
ROSA26-Cre::ERT2+;p16Ink4a-/-, Rac1fl/fl  genotype24, treated with 
hydroxytamoxifen (OHT, to induce deletion of Rac1) and then with siRNA against 
Cyri-b (Supplementary Fig. 3o and Supplementary Fig. 7).  Deletion of Rac1 
led to a spindle-shaped morphology and a loss of lamellipodia as previously 
described 25-27.  Loss of CYRI-B did not cause excessive lamellipodia or rescue 
circularity in Rac-deleted cells (Fig. 3i-k). Thus, Rac1 is absolutely required for 
CYRI-B driven actin reorganisation. 
 
The increased circularity of cyri-b depleted cells is reminiscent of Rac1 
hyperactivation phenotypes28, suggesting that CYRI-B might buffer Rac1 activity. 
Indeed, a dark acceptor mTq2-sREACH Raichu FRET probe29, 30 showed a 
consistent increase in Rac1 signaling activity in CYRI-B depleted cells, as 
measured by FRET efficiency in both COS-7 (Fig. 3l-m) and CHL-1 cells 
(Supplementary Figure 3p-q), which was confirmed by biochemical pulldown 
(Fig. 3n-o and Supplementary Fig. 7).  Together, these data indicate an 
increase in Rac1 signaling activity in CYRI-B depleted cells.  Conversely, 
inducible overexpression of untagged CYRI-B (Supplementary Fig. 4a-b and 
Supplementary Fig. 7) resulted in fractal-like lamellipodia, decreasing WAVE2 
recruitment, cell area and circularity (Fig. 4a-d, Supplementary Fig. 4c-f – 
Vehicle-treated controls).  In parallel, overexpression of CYRI-B also drove a 
decrease in the Rac1 activity signal of the Raichu FRET probe (Fig. 4e-f) which 
was fully reversed by an R160/R161 double mutation (Fig. 4g). Thus, CYRI-B 
opposes Rac1-Scar/WAVE mediated expansion of lamellipodia protrusions.  
Adding a GFP-tag to either end of CYRI-B interfered with its function, precluding 
dynamic analysis, likewise, available antibodies to Fam49B did not give specific 
staining by immunofluorescence, but CYRI-B-FLAG showed significant co-
enrichment with WAVE2 at leading pseudopods (Fig. 4h-i).  Thus CYRI co-
accumulates with WAVE2 at lamellipodia protrusions. Overall, cyri-b knockout 
cells show broader Scar/WAVE driven lamellipodia and increased Rac1 
activation, supporting a role for CYRI-B as a buffer of Rac1 and Scar/WAVE 
complex activation activity at the leading edges of cells. 
 
CYRI regulates the duration and extent of protrusions 
We next sought to determine the consequences of CYRI-B depletion for 
lamellipodial actin dynamics.  First, we observed actin dynamics live using fast 
frame-rate videos in CHL-1 cells expressing GFP-Lifeact (Fig. 5a – Left panel and 
Supplementary Movie 2).  We tracked the cell edge and used unwrapped 
(polar) kymographs (Fig. 5a middle panels) to visualise and measure the area of 
protrusion (yellow colour) versus retraction (purple colour) over time.  Control 
cells showed small but rapid bursts of actin-based protrusion (yellow patches on 
kymograph), while cyri-b knockouts had longer-lived less dynamic responses 
(Fig. 5a,b). If CYRI-B buffers Rac1 at the lamellipodium, we speculated that cyri-
b knockout cells would struggle to restrain protrusion formation upon Rac1 
activation. To investigate this, we used the Rac1-LOV optogenetic probe, which 
triggers activation of Rac1 with blue light 31. Rac1 was activated with pulses of 
blue light in a discrete area on the cell periphery (Fig. 5c-d and Supplementary 
Movie 3).  Cyri-b knockout cells showed a more sustained and extensive 
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protrusion response and increased peripheral propagation of lamellipodia (Fig. 
5e-g).  Thus, CYRI-B limits Rac1- mediated activation of the Scar/WAVE complex 
and shortens the Rac1-activated protrusion. 
 
CYRI focuses actin assembly in leading pseudopods to promote plasticity of 
migration 
Plasticity of protrusion is important for directional migration, such as during 
chemotaxis. CHL-1 melanoma cells are normally nearly static when seeded at 
low density in 2D-culture, but cyri-b knockout cells migrated 1.5-2-fold faster 
(Fig. 6a-b and Supplementary Movie 4).  Cyri-b knockout cells frequently 
assumed a C-shape, with a broad spread lamellipodium at the front half of the 
cell and a convex rear which resembled the fast-moving goldfish keratocyte 32 
(Supplementary Fig. 5a yellow arrows, Supplementary Movie 4).  C-shaped 
cells moved faster than the other common shapes (Fig. 6c,d) and C-shape 
correlated with faster migration (Fig. 6e-f and Supplementary Fig. 5b-c). 
Lamellipodia need to be polarized and dynamic for efficient cell migration27, 33, 
so when cyri-b knockout cells became polarized into a C-shape, they gained 
motility.  
 
Since cells need to maintain plasticity of their lamellipodia to respond effectively 
to directional cues34, we predicted that depletion of CYRI-B would affect 
chemotactic migration.  CHL-1 cells are not chemotactic to serum, but WM852 
melanoma cells are highly chemotactic35.  Loss of CYRI-B (Supplementary Fig. 
5d-e and Supplementary Fig. 7) severely affected chemotaxis of these cells 
towards serum with no effect on basal speed; Knockouts often migrated very 
long distances in the opposite direction to the chemoattractant gradient, having 
lost the plasticity to reorient toward the gradient (Fig. 6g-i and Supplementary 
Movie 5).  Thus, CYRI-B strongly impacts how cells polarize and remodel their 
lamellipodia and reorient during directed migration. 
 
CYRI promotes pseudopod splitting and opposes persistent migration in 
Dictyostelium 
We examined Dictyostelium cells (Ax3, cyri knockout and rescue - 
Supplementary Fig. 5f and Supplementary Fig. 7) migrating under agarose up 
self-generated gradients of the chemoattractant folate36 (Supplementary Fig. 
5g).  Similar to CHL-1 cells, cyri knockout cells were rounder, with blunted 
pseudopods (Fig. 6j-k, Supplementary Movies 6-7).  Dictyostelium cells 
primarily turn by splitting their leading pseudopod into differently-oriented 
daughters8; cyri knockouts generated fewer protrusions/min (Fig. 6l) and 
showed fewer splits (from ~5/min to ~2/min, Fig. 6m) and decreased speed 
(Fig. 6n).  Cells still oriented towards the folate gradient, but their less efficient 
turning was clearly reflected by a smaller angle of turn between steps 
(Supplementary Fig. 5h).  Thus, CYRI promotes pseudopod splitting in 
Dictyostelium cells, which is dispensible for gradient sensing, but compromises 
the speed of migration and reorientation while steering. 
 
We rescued Dictyostelium cyri knockouts with CYRIWT or CYRIR155/156D as stable, 
single-copy transfectants37 under an actin15 promoter (Fig. 6 j-n, 
Supplementary Movies 6-7).  CYRIWT expressing cells exhibited more 
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numerous fractal pseudopods as well as decreased circularity and enhanced 
frequency of protrusion generation and pseudopod splitting (Fig. 6j-m) even 
over WT cells. Rescue with CYRIWT also restored cells’ ability to turn during 
chemotaxis (Supplementary Fig. 5h). 
 
Another widely- used chemotaxis assay involves a chemoattractant-filled 
microneedle introduced just next to Dictyostelium cells, inducing new 
pseudopods directly toward the needle, and consequently reorienting the cells.  
When cyclic-AMP (cAMP)-sensitive cyri knockout or rescue cells were challenged 
with cAMP in a needle assay, cyri knockouts were initially unable to form new 
pseudopods (Fig. 6o), while CYRIWT cells rapidly protruded pseudopods and 
reoriented toward the needle (Figure 6o-p and Supplementary Movie 8).  Cyri 
knockouts eventually elongated and streamed toward the needle, but they 
maintained resistance to new pseudopod formation and rapid reorientation.  
Thus, cells that lack CYRI can still sense an attractant gradient, but their broad 
and unfocussed protrusions split rarely, and their diminished ability to generate 
new pseudopods cripples their response to changing gradients. 
 
 
 
Modeling CYRI’s role in pseudopod plasticity 
Since CYRI affects plasticity of pseudopod dynamics, we likened its activity to the 
mathematical model of Meinhardt 38, where local inhibitors are recruited by an 
activation signal and limit the amount of cell edge devoted to pseudopods.  Actin 
assembly pathways are not linear cascades, but rather feedback loops where 
positive stimulation is self-reinforcing and causes further activation until 
overcome by negative feedback1, 10.  In models of migration based around 
positive feedback, a locally-acting inhibitor is also needed to destabilise existing 
pseudopods, so the cell can change direction. Without this, cells polarize, but 
cannot turn to migrate toward an attractant.  We used a modified version of a 
published simulation39 based on the Meinhardt model38 to visualise the 
concentrations of the activator and the local inhibitor at the cell edge 
(Supplementary Fig. 5i and Supplementary Movie 9), to illustrate the how 
CYRI-B regulates Rac1 and Scar/WAVE signaling.  A peak in the activator (which 
represents active Rac1 and Scar/WAVE) results in the formation of a new 
pseudopod.  The peak also causes an increase in the concentration of the local 
inhibitor, which is smaller and thus diffuses faster38.  Initially, the inhibitor limits 
the lateral spread of the pseudopod (Supplementary Fig. 5i, panel 1); later, 
levels of inhibitor rise in the middle of the pseudopod, destabilizing it and 
causing a split (Supplementary Fig. 5i, panel 2). The weaker of the pseudopods 
then retracts and the stronger is reinforced until the cycle of inhibition catches 
up with it and re-starts the splitting cycle (Supplementary Fig. 5i, panels 3-4).  
The local inhibitor thus increases both the morphological complexity of the cell 
and the competition between pseudopods. This is supported by the lack of 
pseudopod splitting in Dictyostelium and our optogenetic data showing that 
protrusions in cyri knockout cells are more long-lived and spread laterally to a 
greater extent.  Thus, Meinhardt’s model offers insight into the role of CYRI 
proteins as local inhibitors, which enhance leading edge dynamics and add 
plasticity to the positive feedback loops driving migration. 
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CYRI-B regulates epithelial polarity via a Rac1-dependent mechanism 
Finally, we tested a role for CYRI-B the polarized epithelial cyst 40, 41 where 
asymmetric Rac1 activation is also crucial.  As cells form a cyst, they establish a 
lumen via selective membrane trafficking and polarized recruitment/activation 
of cytoskeletal components42. Specific spatial regulation is dependent on matrix 
and adhesions, but Rac1 activation also regulates lumen formation43 and is 
specified by differential recruitment of the GEF TIAM1 across the cyst, leading to 
an apico-basal activation gradient40. We hypothesized that CYRI-B might help 
maintain the Rac1 activation gradient, allowing Scar/WAVE complex 
recruitment and activation to be spatially controlled during cyst formation.  
Indeed, knockdown of CYRI-B using shRNA in MDCK cells (Supplementary Fig. 
6a-b and Supplementary Fig. 7) led to a multilumen phenotype during cyst 
formation, similar to deregulation of active Rac1 (Figure 7a-b, 42). WAVE2 is 
normally prominently localized to the basolateral surfaces of the cysts, but 
mostly absent from the luminal surface, as marked by podocalyxin (PODXL) (Fig. 
7c). However, when CYRI-B was depleted, WAVE2 staining was increased at the 
luminal periphery coincident with PODXL staining (Fig. 7c).  Mislocalisation of 
the actin cytoskeleton machinery to cyst luminal surfaces results in aberrant 
orientation of the mitotic cleavage plane during polarized cell division, which 
occurred in cyri-b knockdown cysts (Supplementary Fig. 6c-e).  To test 
whether the multilumen phenotype was due to inappropriate Rac1 activation, 
we used moderate concentrations of either EHT1864 (Fig. 7d-e) or NSC23766 
(Supplementary Fig. 6f) to dampen Rac1 activity; these both provided a 
substantial rescue.  Thus, loss of CYRI-B destabilised epithelial polarity during 
the formation of epithelial cell cysts by allowing inappropriate Rac1-mediated 
recruitment of the actin machinery to the nascent luminal surface. CYRI-B thus 
maintains spatial regulation of activation of the Scar/WAVE complex by dynamic 
buffering of Rac1. 
 
Discussion 
CYRI is highly conserved and DUF1394 represents a Rac1 interaction 
module 
CYRI proteins are highly conserved in eukaryotes and function as a Rac1 
interaction module that directly limits Rac1-mediated lamellipodia extension.  
The DUF1394 domain of CYRI comprises the Rac1 binding site and is shared with 
CYFIP proteins of the Scar/WAVE complex.  This interaction requires two highly 
conserved arginine/lysine residues, previously described on CYFIP13. CYRI, like 
CYFIP1, is specific for activated Rac1 over RhoA and Cdc42.  Myristoylation of 
glycine 2 of CYRI may allow recycling of CYRI between active pseudopods and 
the cytoplasm or membrane vesicles 44. The Rac1-interacting formin FMNL2 is 
also myristoylated45, implying potential common mechanisms for recruitment to 
actin protrusions.  CYRI has no homology to GTPase activating proteins (GAPs), 
so it likely doesn’t alter nucleotide hydrolysis by Rac1. Why would a cell need 
CYRI if it has Rac-GAPs? We propose CYRI could be a specific buffer for 
Scar/WAVE-driven lamellipodia plasticity, rather than a general protein to turn 
off Rac1. 
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CYRI opposes recruitment of active Scar/WAVE complex to leading edges 
and promotes plasticity 
 
Modulating the levels of CYRI differently affected cell speed in the cell types we 
assayed.  While this may seem paradoxical, the basal speeds of these cell types 
and modes by which they migrate are different.  Furthermore, migration speed is 
multiparametric, being the result of a combination of protrusion, adhesion and 
directionality/persistence.  Migration speed is thought to require optimal levels 
of Rac1 activation and can be slowed by too little/much active Rac133. 
Dictyostelium are optimized by nature to be fast-moving and relatively non-
adhesive, so nearly any change will result in slower migration.  In contrast, the 
speed of adhesive slow-moving cancer cells may benefit from removing the 
brakes on Rac1 activity. 
 
Negative regulators of Arp2/3 complex have been described 11, 12, 46, but thus far, 
CYRI is the only negative regulator of the Scar/WAVE complex.  Importantly, it is 
widely conserved in evolution along with the Scar/WAVE complex, so is a 
universal negative regulator.  CYRI and CYFIP likely resulted from an ancient 
gene duplication and retained the same Rac1 binding function, placing CYRI as a 
Meinhardt local inhibitor38.  But a local inhibitor should be present at high 
enough concentration to compete with the activator.  A recent quantitative mass 
spectrometry study estimated concentrations of CYRI-B to be 4-fold higher in 
protein copy number than Scar/WAVE complex 47 in 3 of 4 cell lines (A549 4-
fold, HepG2 5-fold, PC3 4.4-fold and U87 0.53-fold, based on comparison with 
CYFIP1).  Thus, there is likely enough CYRI-B in cells to compete with the 
Scar/WAVE complex for Rac1 binding. 
 
CYRI provides spatiotemporal regulation of the connection between Rac1 
and Scar/WAVE complex 
Cell migration involves cycles of protrusion and retraction coupled with 
adhesion to produce forward locomotion 48. Cells with wild-type levels of CYRI 
showed rapid protrusion-retraction dynamics indicative of transient activation 
of the Scar/WAVE complex (e.g. kymograph Fig. 5a).  cyri knockouts showed 
broader and more sustained lamellipodia and increased Scar/WAVE 
recruitment, placing CYRI as a key part of the feedback loop controlling leading 
edge actin dynamics, in line with Arpin, a negative regulator of the Arp2/3 
complex 12 and coronin, which positively regulates Rac1 activation 49, 50,1.  
Breaking the feedback loop by deleting CYRI affected both Scar/WAVE 
recruitment and Rac1 signalling activity.  Thus, the actin machinery feeds back to 
Rac1 dynamically.  This dynamic feedback is necessary for cells to change 
direction and respond with plasticity to stimuli such as chemotactic gradients. 
 
CYRI also regulates polarized function of Rac1-Scar/WAVE complex in epithelial 
cells in 3D. Epithelial cells establish a Rac1 gradient that maintains polarity by 
asymmetric distribution of 2-syntrophin and Par3 40.  Par3, localized apically, 
inhibits the Rac-GEF TIAM1, while 2-syntrophin, localized basally, activates 
TIAM1.  This gradient is required for proper luminogenesis.  CYRI helps direct 
formation of a single polarized lumen by regulating the Rac1 gradient required 
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for proper spindle orientation. A role for CYRI in epithelia could have broad 
implications for development and cancer. 
 
Cell migration is the outcome of feedback loops that control the dynamics of cell 
shapes 10, 38, 51-53.  Travelling and spreading wave patterns (for example 10, 51) 
manifest in actin-based protrusions, implying positive feedback loops.  However, 
negative feedback is also required38 to prevent uniform activation.  Actin and 
actin-binding proteins can comprise an excitable system 10, 52 also  modulated by 
systems involving small GTPases, kinases and signaling lipids e.g.9.  Our data 
imply that CYRI acts at the interface; by competing with Scar/WAVE (an actin-
nucleating complex) for Rac1 (a small GTPase) it connects signaling with actin 
polymerization, moderating excitable behaviours. 
 
In conclusion, we propose that CYRI is a highly conserved regulator of the 
dynamics of the Rac1 – Scar/WAVE pathway, providing plasticity and adding 
complexity to leading edge dynamics.  
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Figure Legends 
 
Figure 1 - CYRI (Fam49) proteins show homology to CYFIP and contain a 
putative Rac1 interaction motif 
 
a – Volcano plot illustrating pooled results from four LC-MS/MS experiments 
showing comparison of formaldehyde crosslinked proteins co-
immunoprecipitating with GFP or GFP-NAP1 in Dictyostelium napA knockout 
cells. Color-coding based on two-tailed Welch’s t test difference. Curved line is 
5% false discovery rate. Identified interactors are labeled with gene symbols and 
presented in Supplementary Table 2. (n=4 independent experiments). 
 
b – Schematic of human CYFIP1/2 and CYRI-A/B showing amino acid numbers 
and domains. Common DUF1394 domain (Pfam PF07159) in red and CYFIP1/2 
C-terminal cytoplasmic Fragile X Mental Retardation FMR1-interacting domain 
(FragX-IP, Pfam PF05994) in light green. 
 
c - Two views of ribbon crystal structure of the Scar/WAVE complex (PDB 
3P8C)2. NCKAP1 in lilac, CYFIP1 in light green and red, Scar/WAVE in peach, 
HSPC300 in yellow and ABI1 in orange. DUF1394 is red, with putative Rac1 
interaction residues in blue and highlighted by arrows. 
 
d – Phyre prediction of structure of the DUF1394 domain of CYRI-B. The putative 
Rac1-binding domain of CYRI is blue with Arg160 and Arg161 indicated as a 
stick representation. 
 
e - Sequence alignment of the putative Rac1-binding domain of CYRI in different 
organisms. The CYFIP Lys189 and Arg190 equivalent residues are well 
conserved in CYRI (Arg160 and Arg161) and are highlighted in red. 
 
f - Sequence alignment covering the N-terminal region of CYRI from 
representative evolutionarily diverse eukaryotes. UniProt accession numbers are 
reported. Color code represents the number of entries with an identical amino 
acid at this position. The glycine in the 2nd position (highlighted red) is a putative 
myristoylation site. 
 
g-h - CLICK chemistry analysis of the glycine 2 of CYRI-B. Myristoylation was 
labeled in HEK293T cells and measured by incorporation of myristate-azide 
(green) in GFP, CYRI-BWT-GFP or CYRI-BG2A-GFP mutant transfected cells 
(magenta), following GFP immunoprecipitation. Molecular markers shown left 
(g) See also Supplementary Fig. 7 and Supplementary Table 6. Relative 
incorporation was quantified by densitometry and reported in (h). One way 
ANOVA with Tukey post-test was applied. *** p<0.001. (n=3 independent 
assays). Bar graph represents mean and S.E.M. 
  
 13 
Figure 2 - CYRI proteins interact with active Rac1 
 
a-c - Western blot pulldown of GST control, GST-Rac1WT or GST-Rac1Q61L beads, 
mixed with lysates expressing GFP alone, positive control PAK1 eCFP-CRIB-PBD, 
GFP-RBDWT, GFP-RBDR160D or GFP-RBDR161D (a). Densitometry is relative to GST 
(b-c). (n=3-4 independent experiments, see also Supplementary Fig. 7). 
 
d-f - Western blot pulldown of GST control, GST-Rac1P29S or GST-Rac1Q61L or 
double mutant GST-Rac1P29S/Q61L beads, with cell lysate expressing either GFP 
alone, eCFP-CRIB-PBD, GFP-RBDWT (d). Densitometry is relative to GST (e-f). 
(n=3 independent experiments, see also Supplementary Fig. 7). 
 
g – Steady state surface plasmon resonance (SPR) binding curves between 
Rac1Q61L and CYRI-B-RBD. Left: GST-CYRI-B was immobilized vs increasing 
concentrations of Rac1Q61L.  Right: His-Rac1 immobilised vs increasing 
concentrations of CYRI-B RBD. Simple 1:1 binding model. Kd = equilibrium 
dissociation constant, A.U. = arbitrary units. 
 
h-i Proximity ligation assay with COS-7 cells on laminin and co-expressing either 
CYRI and Rac1 constructs as indicated.  PLA signal (yellow), F-actin (magenta) 
and nuclei (blue). See Supplementary Fig. 2 for negative controls.  
Quantification of 4 independent experiments in (i).  One-way ANOVA with 
Dunn’s post-test between CYRI-BWT and MYC-Rac1 constructs. Two-tailed Mann 
Whitney test between CYRI-BWT and CYRI-BR160/161D for each MYC-Rac1 
construct. n.s. p> 0.05, ** p≤0.01, *** p≤0.001. (anti-HA n=55; anti-Myc n=54; 
Myc-WT/WT-HA n=55; Myc-WT/R160-161D-HA n=55; Myc-T17N/WT-HA 
n=63; Myc-T17N/ R160-161D-HA n=84; Myc-Q61L/WT-HA n=69; Myc-Q61L/ 
R160-161D-HA n=65, where n=cells) 
Scale bar = 50 μm. 
 
j - Still pictures from mitochondrial recruitment of CYRI (Forward) or 
Rac1AP29S/Q61L (Reverse) in Ax3 D. discoideum. Quantification (Imaris) showed 
Pearson’s coefficient of correlation (PCC) for co-localisation (standard deviation 
SD and n number of cell) at the mitochondria for Rac1A-mCherry-mito and the 
GFP-fusions: CRIB-PBD 0.80 (SD: 0.20 – n=6 cells) ; CYRIWT 0.77 (SD: 0.21 – n=8 
cells) ; CYRIR155/156D 0.05 (SD: 0.12 – n=14 cells).  The correlation coefficients for 
Rac1A-mCherry and the GFP-CYRI-mito fusions were: CRIB-PBD 0.33 (SD: 0.12 – 
n=6 cells) ; CYRIWT 0.44 (SD: 0.19 – n=12 cells) ; CYRIR155/156D -0.23 (SD: 0.05 – 
n=6).  Cells co-expressing a mitochondrial reporter (mCherry-gemA tail) and 
CYRI-GFP were also imaged (right panel), confirming the absence of 
mitochondrial localisation of CYRI. The correlation coefficient was -0.06 (SD: 
0.15 – n=6 cells).  
(For all experiments, >300 mitochondria/cell). Scale bar = 5 μm 
(See also Supplementary Fig. 7) 
 
Data in a-j represent at least 3 biologically independent experiments. Bar and 
scatter plots show data points with mean and S.E.M. unless indicated.  Source 
data in Supplementary Table 6. 
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Figure 3 - Loss of CYRI-B increases Rac1-mediated Scar/WAVE localisation 
to lamellipodia 
 
a-d - Immunofluorescence of control (Ctr) or cyri-b knockdown (siRNA #1 and 2) 
COS-7 showing WAVE2 (green), nuclei (blue) and F-actin (magenta). Scale bar = 
50 μm. Box insets zoom, scale bar = 10 μm. 
Ratio of WAVE2 (yellow dotted line) vs total cell perimeter (b). Cell area in (c) 
and circularity (d). One-way ANOVA with Dunn’s post-test n.s. p> 0.05, *** 
p≤0.001.  (a-c: Scramble n=111; #1 n=95; #2 n=96 – d: Scramble n=115; #1 
n=92; #2 n=98) n represents cells in a-o. 
 
e-f –COS-7 with cyri-b knockdown and rescued with pLIX-mVenus si-resistant 
CYRI-B (WT or R160/161D) or empty vector (EV). (see Supplementary Fig. 3l). 
Cell area (e) and circularity (f). One-way ANOVA with Dunn’s post-test n.s. p> 
0.05, *** p≤0.001. (Scramble/EV n=78; Scramble/WT n=58; Scramble/R160-
161D n=66; #1/EV n=66; #1/WT n=64; #1/R160-161D n=60). 
 
g-h – Control or cyri-b knockdown COS-7 with pLIX-mVenus and si-resistant 
CYRI-B (WT or G2A mutant) or EV. Cell area (g) and circularity (h). One-way 
ANOVA with Dunn’s post-test n.s. p> 0.05, *** p≤0.001. (Scramble/EV n=70; 
Scramble/WT n=52; Scramble/G2A n=46; #1/EV n=63; #1/WT n=64; #1/G2A 
n=65) 
 
i-k - Control (DMSO) or rac1 knockout  (OHT) mouse tail fibroblasts with 
Scramble (siCtr) or Cyri-B siRNA, showing WAVE2 (i). Scale bar = 50 μm. 
Lamellipodial WAVE2 (j) and circularity (k). One-way ANOVA with Dunn’s post-
test *** p≤0.001. two-tailed Mann Whitney test between OHT and control. ### 
p≤0.001. (n=30 cells/condition). 
 
l-m - FLIM/FRET of mTq2-sREACH in control (siCtr) or cyri-b knockdown 
(siCYRI-B #1 and #2) COS-7. Jet2 color code (left) average lifetime, 1-4 ns blue to 
red. (l). FRET efficiency (m). One-way ANOVA with Dunn’s post-test. *** p≤0.001. 
(Scramble n=61; #1 n=61, #2 n=63) 
Scale bar = 50 μm 
 
n-o - Active Rac1 pulldown comparing control CrispR (VectorCtr) or  independent 
cyri-b CrispR (#1 and #2) COS-7 lines. See also Supplementary Fig. 7. 
 
Data in a-o represent N= 3 biologically independent experiments.  All cells plated 
on laminin.  See also Supplementary Table 6. 
Bar and scatter plots show data points with mean and S.E.M. 
Whisker plots show 10-90 percentile, median (bar) and mean (cross). 
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Figure 4 - Overexpression of CYRI-B opposes Rac1-mediated Scar/WAVE 
recruitment to the leading edge 
 
a-d - Immunofluorescence of doxycycline-induced control empty vector (EV) or 
CYRI-B overexpression in COS-7 cells and fixed after 4h showing WAVE2 
(magenta), nuclei (blue) and GFP (green). Scale bar = 50 μm. Insets show zoom 
of white dashed field. Scale bar = 10 μm (a). WAVE2 ratio and circularity in (b) 
and (c) respectively. Cell area quantification was based on phalloidin staining 
(d). Two-tailed Mann-Whitney test *** p≤0.001. (Dox/EV n=73; Dox/CYRI-B 
n=93) n represents cells in a-i 
 
e-f - FLIM/FRET experiment with mTq2-sREACH Raichu Rac1 showing vehicle 
or doxycycline-treated COS-7 cells expressing a control empty vector (EV) or 
CYRI-B. The jet2 color code (bar at top) shows the average lifetime of the probe, 
spanning 1-4 ns (blue to red) (e). Quantification of the FRET efficiency (f). Two-
tailed Mann-Whitney test n.s. p> 0.05, *** p≤0.001. (Veh/EV n=47; Veh/CYRI-B 
n=46; Dox/EV n=62; Dox/CYRI-B n=62) 
Scale bar = 50 μm. 
 
g - FRET efficiency obtained from control (EV) or COS-7 cells overexpressing 
CYRIWT or CYRI-BR160/161D after doxycycline induction. One-way ANOVA with 
Dunn’s post-test was performed. n.s. p> 0.05, *** p≤0.001. (EV n=59; WT n=62; 
R160/161D n=63). 
h-i - Immunofluorescence of COS-7 cells transfected with CYRI-B-FLAG and 
stained for FLAG-tag (green), F-actin (top row) or WAVE2 (bottom row) 
(magenta) and nuclei (blue). Scale bar = 50 μm (h). FLAG-staining is 
quantified by normalizing the fluorescence intensity running across 17 
representative cells and ending at the protrusive end (normalized distance: 
1=protrusive end and 0=opposite end). FLAG-tag and F-actin staining 
intensity are shown in green and magenta respectively (i) (n=17). 
 
 
Data in a-i represent N=3 biologically independent experiments. 
See also Supplementary Table 6. 
Bar and scatter plots show data points with mean and S.E.M. 
Whisker plots show 10-90 percentile, median (bar) and mean (cross). 
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Figure 5 - CYRI-B controls the duration and extent of Rac1-mediated 
protrusions 
 
a - Control (Vector Ctr) and cyri-b CrispR knockout CHL-1 cells on laminin 
expressing GFP-LifeAct, recorded for 3 minutes at 1 frame/sec. The cell 
periphery (magenta) is tracked using the GFP-LifeAct signal (green) (Left panel). 
The membrane is unravelled from the orange arrow and a representative polar 
kymograph of the changes in membrane dynamics over time between control 
(Vector Ctr - Top) and cyri-b CrispR knockout (Bottom) CHL-1 cells is shown. 
Membrane extensions (positive values) are visualised in yellow through to 
orange, while retractions (negative values) are purple-blue (Middle 
panel). Thresholding of the kymograph to remove noise (values ≥ + 0.6) reveals 
protrusions over time (white signal – Right panel) 
Still from movie S2. Scale bar = 25 μm.  
 
b - Box plot representing the distribution of the average protrusion lifetime for 
each individual cell. Whisker plots represent mean and S.D. Two-tailed Mann 
Whitney test. *** p≤0.001. (n= 20 cells/condition) 
 
c - Schematic representation showing protruding (blue) and retracting 
(magenta) area following photoactivation of Rac1-LOV probe. Photo activation 
area (green circle) was used as the origin to measure the maximal protrusion 
distance (outward - black line) and the longest uninterrupted lateral spread of 
the protrusion (red dotted line)  
 
d - Still pictures from videos of photoactivation time course showing selected 
cells from DMSO (Control) or OHT-treated (knockout) immortalized CRE-ERT2+ 
Cyri-Bfl/fl MEFs on fibronectin.  Endpoint overlay as from schematic (c). Scale bar 
= 25 μm. 
 
e-f - Quantification of the protrusion distance (e) and the spread of activation (f) 
between control (DMSO) or cyri-b knockout (OHT) MEFs.   
Error bars represent 95% CI. Unpaired two-tailed t-test (e) and two-tailed 
Mann-Whitney test (f). *** p≤0.001, **** p≤0.0001. (DMSO n=29 cells; OHT n=30 
cells). 
 
g - Kymograph representation before and after photo activation. Membrane 
extensions are visualised in yellow through to orange, while retractions are 
observed in purple-blue. Time of photoactivation is highlighted by a white dotted 
line. 
 
Data in a-g represent N=3 biologically independent experiments. 
See also Supplementary Table 6. 
  
 17 
Figure 6 - CYRI proteins mediate plasticity of protrusions needed for 
directional migration 
 
a-c - Spider plots of control (Vector Ctr) or cyri-b CrispR knockout (#1 and #2) 
CHL-1 cells on collagen-I for 17h (a) (See movie S4). Black and red lines = 
distance > or <100 μm respectively. Average speed (b). Whisker plots 10-90 
percentile and mean (cross). (c)– Duration as C-shape (Vector Ctr) and cyri-b 
CrispR knockout (#1 and #2) CHL-1 cells. (b,c) One-way ANOVA with Dunn’s 
post-test *** p≤0.001. (b) (Ctr n=161; #1 n=228; #2 n=178). (c) (Ctr n=45; #1 
n=53; #2 n=42).  n represents cells in a-p.   
 
d - Speed of control (Vector Ctr) or cyri-b CrispR knockout (#1 and #2) CHL-1 in 
shapes as indicated. One-way ANOVA with Dunn’s post-test  n.s. p>0.05, * p≤0.05, 
*** p≤0.001. (Ctr n=45; #1 n=53; #2 n=42) 
 
e-f - Immunofluorescence of control (Vector Ctr) or cyri-b CrispR knockout (#1 
and #2) CHL-1 cells on collagen. F-actin (magenta) and nuclei (blue) (e). Scale 
bar = 50 μm. Shape categories: Fried-egg, C-shape, Random (f). Two-tailed Chi-
square test (95% confidence). *** p≤0.001. (Ctr n=276; #1 n=216; #2 n=210) 
 
g-i - Spider and Rose plots of control (Vector Ctr) or cyri-b knockout WM852 cells 
migrating toward 10% FBS (g) (see movie S5). Red-dashed lines 95% 
confidence interval for mean direction. Cosθ (chemotactic index) (h) average 
speed (i). Two-tailed unpaired t-test. n.s. p>0.05, ** p≤0.01. (Ctr n=129; #1 
n=132; #2 n=151). 
 
j-n - DIC pictures from Dictyostelium under-agarose chemotaxis (j) (see movie 
S6). Scale bar = 10 μm. Automatic cell segmentation and tracking reveals 
circularity (k), protrusions (l), split frequency (m), and speed (n). Whisker plots 
show 10-90 percentile (k-m) and 1-99 percentile (n) with median (bar) and 
mean (cross). One-way ANOVA with Dunn’s post-test. n.s. p>0.05, * p≤0.05, *** 
p≤0.001. (k: WT n=360; cyri KO n=352; cyri KO + CYRI WT n=480; cyri KO + CYRI 
R155/156 n=240 - l: WT n=45; cyri KO n=57; cyri KO + CYRI WT n=53; cyri KO + CYRI 
R155/156 n=31 - m: WT n=42; cyri KO n=62; cyri KO + CYRI WT n=46; cyri KO + CYRI 
R155/156 n=33 - n: WT n=2389; cyri KO n=2460; cyri KO + CYRI WT n=3024; cyri KO 
+ CYRI R155/156 n=1169) 
 
o-p - Needle assay using WT or cyri knockout Ax3 cells migrating toward cAMP 
(see also movie S8) (yellow start). Scale bar = 25 μm (o). Spider plots during 0-
100 seconds following needle re-orientation (p). (WT n=86; cyri KO n=79) 
 
Data in a-p represent N=3 biologically independent experiments. 
Bar and scatter plots show data points with mean and S.E.M unless indicated. 
See also Supplementary Table 6. 
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Figure 7 - CYRI-B regulates Rac1-dependent recruitment of Scar/WAVE 
complex during epithelial cystogenesis 
 
a-b – Immunofluorescence of control (Vector Ctr) or cyri-b shRNA knockdown 
(#1 and #2) MDCK cysts fixed after 5 days of culture and stained for Podocalyxin 
(PODXL) (green), F-actin (red) and nuclei (blue). Top row is a confocal section 
and bottom row represents Z-maximal projection intensity of PODXL staining. 
Scale bar = 50 μm (a). Quantification of lumens in (b). One-way ANOVA with 
Dunn’s post-test. *** p<0.001. (Ctr n=1000 cysts, #1 n=1000 cysts, #2 n=800 
cysts). 
c - Immunofluorescence of control (Vector Ctr) or cyri-b shRNA knockdown (#1 
and #2) MDCK cysts stained for WAVE2 (green) and Podocalyxin (PODXL) (red) 
after 5 days of culture. Inverted LUT images, merge and representative surface 
profile plots shown. PODXL (red) and WAVE2 (green) staining intensity was 
measured along the blue line. Scale bar = 9 μm. Insets provide a magnified view 
of the dotted square area. Scale bar = 5 μm.  
d-e – Immunofluorescence of control (Vector Ctr) or cyri-b shRNA knockdown 
(#1 and #2) MDCK cysts grown during 5 days, treated or not with 50 nM 
EHT1864 and stained for Podocalyxin (PODXL). Pictures represent the Z-
maximal projection intensity from a representative z-stack running across the 
entire cyst volume. Scale bar = 50 μm (d). Number of lumens per cyst was 
quantified for vehicle or EHT1864-treated cysts and plotted in (e). One-way 
ANOVA with Dunn’s post-test between control (Vector Ctr), shCYRI-B #1 and 
shCYRI-B #2 whereas unpaired two-tailed t-test between vehicle and drug-
treated cyst. n.s. p>0.05, ** p≤0.01 *** p≤0.001. (250 cysts/condition) 
Data in a-e represent N=3 biologically independent experiments. 
Bar and scatter plots show data points with mean and S.E.M. 
Whisker plots show 10-90 percentile, median (bar) and mean (cross). 
See also Supplementary Table 6. 
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